203 related articles for article (PubMed ID: 37688712)
1. Opioid-induced Neurotoxicity in Patients with Cancer Pain.
Mercadante S
Curr Treat Options Oncol; 2023 Oct; 24(10):1367-1377. PubMed ID: 37688712
[TBL] [Abstract][Full Text] [Related]
2. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
3. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
[TBL] [Abstract][Full Text] [Related]
4. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
[TBL] [Abstract][Full Text] [Related]
5. Methadone-Induced Neurotoxicity in Advanced Cancer: A Case Report.
Hoff AM; Hartwig KN; Rosielle DA
J Palliat Med; 2017 Sep; 20(9):1042-1044. PubMed ID: 28488910
[TBL] [Abstract][Full Text] [Related]
6. Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.
Bates N; Bello JK; Osazuwa-Peters N; Sullivan MD; Scherrer JF
Curr Treat Options Oncol; 2022 Mar; 23(3):348-358. PubMed ID: 35254595
[TBL] [Abstract][Full Text] [Related]
7. Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810).
González-Barboteo J; Porta-Sales J; Nabal-Vicuña M; Díez-Porres L; Canal-Sotelo J; Alonso-Babarro A; Vílches-Aguirre Y; Pérez-Pujol S; Sanllorente M; Llorens-Torromé S; Gómez-Batiste Alentorn X; Bruera E
J Palliat Med; 2021 Mar; 24(3):382-390. PubMed ID: 32749916
[No Abstract] [Full Text] [Related]
8. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting.
Okayama S; Matsuda Y
J Hosp Palliat Nurs; 2021 Dec; 23(6):539-543. PubMed ID: 34334770
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
10. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
Khoo SY; Aziz FA; Nambbiar P
J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
[TBL] [Abstract][Full Text] [Related]
11. Methadone for cancer pain: what have we learned from clinical studies?
Soares LG
Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
[TBL] [Abstract][Full Text] [Related]
12. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
[TBL] [Abstract][Full Text] [Related]
13. Intravenous methadone in a patient with advanced cancer.
Picco Brunetto AG
BMJ Support Palliat Care; 2019 Sep; 9(3):277-279. PubMed ID: 30274971
[TBL] [Abstract][Full Text] [Related]
14. Hyperalgesia and opioid switching.
Mercadante S; Arcuri E
Am J Hosp Palliat Care; 2005; 22(4):291-4. PubMed ID: 16082916
[TBL] [Abstract][Full Text] [Related]
15. Reply to "A better interpretation of data regarding the opioid switching to methadone".
Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
BMC Palliat Care; 2023 Jun; 22(1):66. PubMed ID: 37280625
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of Opioid Switching to Methadone for Cancer Pain Control in Successful and Unsuccessful Cases.
Okayama S; Matsuda Y; Yoshikawa Y
J Palliat Med; 2019 Jul; 22(7):844-847. PubMed ID: 30716000
[No Abstract] [Full Text] [Related]
17. The Use of Low-Dose Methadone as Add-On to Regular Opioid Therapy in Cancer-Related Pain at End of Life: A National Swedish Survey in Specialized Palliative Care.
Fürst P; Lundström S; Klepstad P; Strang P
J Palliat Med; 2020 Feb; 23(2):226-232. PubMed ID: 31436477
[No Abstract] [Full Text] [Related]
18. How to Use Methadone in an Era of an Opioid Epidemic.
Heung Y; Reddy A
Curr Treat Options Oncol; 2020 Mar; 21(4):30. PubMed ID: 32193644
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Validation for the "BJR method"-A Possible New Mathematical Approach to Methadone Conversion.
Trofimovitch D; Hutchinson L; Baumrucker SJ
J Pain Palliat Care Pharmacother; 2019; 33(1-2):42-48. PubMed ID: 31260376
[TBL] [Abstract][Full Text] [Related]
20. Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care.
Lim KH; Nguyen NN; Qian Y; Williams JL; Lui DD; Bruera E; Yennurajalingam S
J Palliat Med; 2018 Dec; 21(12):1698-1704. PubMed ID: 30260731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
